Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;10(1):40-54.
doi: 10.1002/epi4.13090. Epub 2024 Nov 14.

Defining neonatal status epilepticus: A scoping review from the ILAE neonatal task force

Affiliations

Defining neonatal status epilepticus: A scoping review from the ILAE neonatal task force

Magda L Nunes et al. Epilepsia Open. 2025 Feb.

Abstract

Objective: To review the available literature concerning the definition of neonatal status epilepticus (SE) and/or seizure burden.

Methods: The International League Against Epilepsy Neonatal Task Force performed a scoping review of the definitions of neonatal SE. Following a systematic literature review, articles were screened and data were abstracted regarding: (1) article characteristics (author identification, publication year, journal name, digital object identifier, title, objective, and study design); (2) cohort characteristics (sample size, gestational age, seizure etiology); (3) definition of SE and/or seizure burden; and (4) the method used to identify and classify SE, including routine EEG (EEG), continuous EEG monitoring (cEEG), amplitude-integrated EEG (aEEG), or clinical features.

Results: The scoping review yielded 44 articles containing a definition of neonatal SE. Studies mainly included infants with hypoxic-ischemic encephalopathy or neonates considered at risk for seizures. SE identification and classification most often relied on cEEG. The majority of studies based the definition of SE on seizure duration, including summed duration of seizures comprising ≥50% of any 1-h epoch, recurrent seizures for >50% of the total recording time, or either electrographic seizures lasting >30 min and/or repeated electrographic seizures totaling >50% in any 1-h period. Seizure burden was reported in 20 studies, and the most commonly used approach assessed total seizure burden, defined as total duration of EEG seizures in minutes. Sixteen studies assessed the relationship between seizure burden and outcomes, and most identified a significant association between higher seizure burden and unfavorable outcomes.

Significance: This scoping review demonstrates a substantial variation in neonatal SE definitions across the literature. The most common definitions were based around a 30-min seizure duration criterion, but evidence was insufficient to support that 30 min was a cutoff defining prolonged seizures or that seizures exceeding this burden were more likely to be pharmacoresistant or associated with worse outcomes. As a next step, the Neonatal Task Force intends to develop a standardized approach to assessing and describing neonatal seizure burden and defining neonatal SE.

Plain language summary: Prolonged seizures are a neurologic emergency, if untreated, can lead to permanent injury or death. In adults and children, seizures lasting longer than 30 min are believed to cause brain damage. However, it is not clear if this definition can be applied to neonates. The International League Against Epilepsy Neonatal Taskforce performed a scoping literature review which identified 44 articles containing a definition of neonatal status epilepticus. In this article, the authors reviewed the current used definitions for prolonged seizures in neonates to establish a relationship between seizure duration and neurological outcome. As a next step, the Neonatal Task Force intends to develop a standardized approach to assessing and describing neonatal seizure burden and defining neonatal SE.

Keywords: neonatal; neurocritical care; outcome; seizure burden; seizures; status epilepticus.

PubMed Disclaimer

Conflict of interest statement

M.L.N. is supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)‐Brazil (PQ 306338/2017–3). C.J.W. receives royalties from Cambridge Publishing, receives a stipend as Associate Editor for Neurology, and receives honoraria from ICON and University of Utah for service on Data Safety Monitoring Boards. R.A.S. receives royalties from UpToDate for authorship of topics related to neonatal seizures; serves as a consultant for the Epilepsy Study Consortium; and receives a stipend for her role as President of the Pediatric Epilepsy Research Consortium®. G.B.B. is founder and co‐director of Kephala Ltd. and CergenX Ltd. She has a consultancy agreement through University College Cork with Nihon Kohden. R.M.P. is an associate editor for Epilepsia‐Open; acts as an Investigator for studies with UCB Pharma; has received honoraria from Longboard, Natus, and UCB Pharma for services on advisory boards, teaching, or consultancy work; is supported by the National Institute of Health Research (NIHR) Biomedical Research Centre at Great Ormond Street Hospital, Evelyn Trust, Cambridge Biomedical Research Centre, and NIHR. K.V. receives a stipend as Associate Editor of Epilepsy & Behavior and research grants from FAPESP and CNPq. She receives honorarium as the Director and Coordinator of Clinical Research Center for Clinical Trials in Complex and Rare Epilepsies. JMW is an associate editor for Epilepsia, chief Editor of Pediatric Neurology subsection of Frontiers in Neurology and is on the South African national advisory boards for Sanofi, Roche, and Novartis. She receives honoraria for work related to these activities. S.L.M. is the Charles Frost Chair in Neurosurgery and Neurology and partially funded by grants from NIH U54 NS100064 (EpiBioS4Rx), RO1‐NS43209 and RO1‐ NS127524, US Department of Defense (W81XWH‐22‐1‐0510, W81XWH‐22‐1‐0210), a pilot grant from the NICHD center grant (P50 HD105352) for the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (RFK‐IDDRC), and the Heffer Family and the Segal Family Foundations, and the Abbe Goldstein/Joshua Lurie and Laurie Marsh/Dan Levitz families. E.M.M. receives royalties from Springer Publishing Company, Princeton, NJ, USA. T.E.I. is a scientific advisor for Aspect Imaging, Realta, and Chiese Pharmaceutical. C.C.T., E.O.P., and N.S.A. no conflict of interest to declare. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.

Figures

FIGURE 1
FIGURE 1
Neonatal Status Epilepticus is an evolving definition; this figure shows a timeline of previous definitions since 1969.
FIGURE 2
FIGURE 2
PRISMA Flowchart for the initial search (top) and update search (bottom).

References

    1. Glass HC, Shellhaas RA, Wusthoff CJ, Chang T, Abend NS, Chu CJ, et al. Contemporary profile of seizures in neonates: a prospective cohort study. J Pediatr. 2016;174:98–103. 10.1016/j.jpeds.2016.03.035 - DOI - PMC - PubMed
    1. Pellegrin S, Munoz FM, Padula M, Heath PT, Meller L, Top K, et al. Neonatal seizures: case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2019;37(52):7596–7609. - PMC - PubMed
    1. Zuberi SM, Wirrell E, Yozawitz E, Wilmshurst JM, Specchio N, Riney K, et al. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: position statement by the ILAE task force on nosology and definitions. Epilepsia. 2022;63(6):1349–1397. 10.1111/epi.17239 - DOI - PubMed
    1. Pressler RM, Cilio MR, Mizrahi EM, Moshé SL, Nunes ML, Plouin P, et al. The ILAE classification of seizures and the epilepsies: modification for seizures in the neonate. Position paper by the ILAE task force on neonatal seizures. Epilepsia. 2021;62(3):615–628. 10.1111/epi.16815 - DOI - PubMed
    1. Pressler RM, Abend NS, Auvin S. Treatment of seizures in the neonate: guidelines and consensus‐based recommendations—special report from the ILAE task force on neonatal seizures. Epilepsia. 2023;00:1–21. 10.1111/epi.17745 - DOI - PubMed

Publication types